Fny Investment Advisers, LLC Galapagos Nv Transaction History

Fny Investment Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	BUY	$52.3 - $71.59 $156,900 - $214,770	3,000 New	3,000 $167,000
Q2 2020 Jul 10, 2020	SELL	$185.52 - $231.25 $575,112 - $716,875	-3,100 Closed	0 $0
Q1 2020 Apr 09, 2020	BUY	$143.0 - $274.03 $333,476 - $639,037	2,332 Added 303.65%	3,100 $607,000
Q4 2019 Jan 10, 2020	BUY	$146.12 - $215.82 $7,013 - $10,359	48 Added 6.67%	768 $158,000
Q3 2019 Oct 25, 2019	BUY	$130.44 - $187.64 $93,916 - $135,100	720 New	720 $109,000
Q1 2019 Apr 17, 2019	SELL	$89.61 - $117.78 $448,050 - $588,900	-5,000 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$87.81 - $110.65 $439,050 - $553,250	5,000 New	5,000 $458,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.